CONTINUECARE HOSP AT PALMETTO HEALTH
1. Target Overview & Investment Thesis
CONTINUECARE HOSP AT PALMETTO HEALTH is a 35-bed community hospital in RICHLAND, SC with $14.1M in net patient revenue and a 1.6% operating margin. The hospital serves a payer mix of 52.4% Medicare, 0.0% Medicaid, and 47.6% commercial.
Thesis: Turnaround. Our ML models identify $1.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.6% to 8.9% (+737bps).
| Net Revenue HCRIS | $14.1M |
| Current EBITDA COMPUTED | $221K |
| Operating Margin COMPUTED | 1.6% |
| Occupancy HCRIS | 64.3% |
| Revenue / Bed COMPUTED | $403K |
| Net-to-Gross HCRIS | 40.7% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of 1.6% places it above the state median. Among 37 size-comparable peers (18-70 beds), the median margin is 1.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (18-70), prioritizing same-state peers. 37 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CONTINUECARE HOSP AT PALMETTO (Target) | SC | 35 | $14.1M | 1.6% |
| PH PATEWOOD HOSPITAL | SC | 64 | $229.8M | 38.0% |
| GEORGETOWN MEMORIAL HOSPITAL | SC | 68 | $168.0M | -4.6% |
| PH GREER MEMORIAL HOSPITAL | SC | 66 | $161.3M | 31.3% |
| PELHAM MEDICAL CENTER | SC | 48 | $137.2M | 17.1% |
| PH HILLCREST HOSPITAL | SC | 43 | $123.6M | 30.8% |
| ROPER ST. FRANCIS HOSPITAL-BER | SC | 46 | $119.0M | 13.0% |
| PH BAPTIST EASLEY HOSPITAL | SC | 64 | $118.3M | 19.6% |
| PH LAURENS COUNTY HOSPITAL | SC | 41 | $109.4M | 13.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.0M (737bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $296K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $282K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $280K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $172K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +7bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $221K |
| + RCM Uplift | +$1.0M |
| Pro Forma EBITDA | $1.3M |
| Current Margin | 1.6% |
| Pro Forma Margin | 8.9% |
| WC Released (1x) | $541K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $340K | $11.9M | 34.82x | 103.4% |
| Base (11x exit) | 10.0x | 11.0x | $340K | $13.2M | 38.63x | 107.7% |
| Bull Case | 9.0x | 11.0x | $306K | $16.7M | 54.48x | 122.5% |
| Bull (12x exit) | 9.0x | 12.0x | $306K | $18.3M | 59.73x | 126.6% |
| Bear Case | 11.0x | 10.0x | $374K | $6.5M | 17.48x | 77.2% |
| Bear (11x exit) | 11.0x | 11.0x | $374K | $7.3M | 19.56x | 81.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 37 hospitals with 18-70 beds
- Same-state prioritization (n=38)
- Comp margins: P25=-13.7% / P50=1.4% / P75=16.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.